Forum Session

Exploring Comparative Effectiveness: Lessons from Across the States and Around the World
February 27, 2009

Manager

Michele J. Orza, ScD

Summary

In the latest of a long succession of proposals intended to expand the nation’s capacity for comparative effectiveness, the recently passed stimulus bill allocates more than a billion dollars to support the development of more and better evidence about what works to promote health. Demand for improved evidence has been coming from many quarters, with patients, clinicians, public and private payers, and insurers all identifying a need for better information on which to base their decisions.

This session was the final in a six-part series and examined comparative effectiveness programs in the states and in other countries, focusing on how these experiences might inform an expanded national program. The speakers for this session were chosen for their knowledge and experience of comparative effectiveness activities in a broad array of states and nations. They described and discussed a recently completed study of 11 countries and a collaborative of 11 state Medicaid agencies.

Speakers

Gerard Anderson, PhD, Professor and Director, Center for Hospital Finance and Management, and Co-director, Program for Medical Technology and Practice Assessment, Johns Hopkins University; Kalipso Chalkidou, MD, PhD, Director, Policy Consulting, National Institute for Health and Clinical Excellence, United Kingdom; Mark Gibson, Deputy Director, Center for Evidence-based Policy, Oregon Health and Science University, and Program Officer, Milbank Memorial Fund

Slides from the presentations by Drs. Anderson and Chalkidou, and Mr. Gibson are available for download. Speakers' biographies are also available.

Related Materials

For details on other sessions in this series, see the individual entries at: "Exploring Comparative Effectiveness: Fundamentals of Evidence-Based Health and Introduction to the Cochrane Collaboration" (July 25, 2008), "Exploring Comparative Effectiveness: Activities of NIH, FDA, and AHRQ to Advance Evidence-Based Health" (September 26, 2008), "Exploring Comparative Effectiveness: Activities of CDC, VA, and CMS to Advance Evidence-Based Health" (October 3, 2008), "Exploring Comparative Effectiveness: Fundamentals and Controversies of Cost-Effectiveness Analysis" (October 30, 2008; ), and "Exploring Comparative Effectiveness: Options for Expanding U.S. Capacity" (December 17, 2008).

In addition, see the February 13, 2009 follow-up session to the Forum's 2009 Medicare and Medicaid Briefings.

For more information about the systems elsewhere in the world and what U.S. leaders might learn from them, see "Comparative Effectiveness Research: International Experiences and Implications for the United States," (AcademyHealth, July 2009). Additionally, for discussion of the system in the United Kingdom, see "Value-Based Coverage Policy in the United States and the United Kingdom: Different Paths to a Common Goal" (National Health Policy Forum, Background Paper, November 2, 2006).

↑ back to top

Browse Topics Side ArrowDown Arrow